Makerere University – College of Health Sciences Celebrating a Century of Excellence, Shaping the Future
You are invited to the Public PhD Defense of Haruna Muhmood Kiryowa (BDS, MSc.).
🗓 Date: Friday, 20th December 2024
⏰ Time: 3:00 PM (EAT)
📍 Venue: MakCHS Conference Room and Online
Thesis Title:
Periodontal Disease in Patients with Diabetes Mellitus Attending Kiruddu National Referral Hospital: Prevalence, Risk Factors, Association with Glycemic Control, and Insulin Resistance
Supervisors:
Assoc. Prof. William Buwembo (PhD)
Assoc. Prof. Erisa S. Mwaka (PhD)
Assoc. Prof. Mark Kaddumukasa
Doctoral Committee:
Assoc. Prof. Charles Rwenyonyi
Dr. Jane Nakibuuka
Internal Examiners:
Assoc. Prof. David P. Kateete
Dr. Isaac Okullo
External Examiner/Opponent:
Assoc. Prof. Tina Roberts
Defense Chair:
Dean, School of Biomedical Sciences, MakCHS
Join us live!
💻 Meeting ID: 862 6246 3585
🔒 Passcode: 280504
🔍 Scan the QR code in the flyer to join the session directly.
The Dean, School of Biomedical Sciences, College of Health Sciences, Makerere University invites you to be part of KULE KYOLO Samuel’s PhD defense scheduled for Thursday 7th November 2024, at 10:00 am (EAT). See details below:
PhD Candidate: KULE KYOLO Samuel
Thesis Title:Assessment of Management of Mental Illnesses in Goma City: A Study of Indigenous Knowledge on Medicinal Plants, Effectiveness and Safety
Dr. Samuel Baker Obakiro (PhD; MSc. Pharm; PGDE; BSc.) Senior Lecturer and Head of Department
Internal Examiners:
Dr. Catherine Abbo, MBChB, MMED (Psychiatry), Cert (Child and Adolescent, Psychiatry), PhD ( Transcultural Psychiatry). Associate Professor / Child and Adolescent Psychiatrist
Dr. Lydia Bunalema, PhD, Department of Pharmacology and Therapeutics, School of Biomedical Sciences, MakCHS
Professor Emeritus Willy W. Anokbonggo (MD, PhD), Professor of Pharmacology, Department of Pharmacology and Therapeutics, School of Biomedical Sciences
Supervisors:
Dr. Godfrey Bbosa (MSc. Pharmacol., MSc. IPHC., M. Neuroscience, PhD), Department of Pharmacology and Therapeutics, MAKCHS, Kampala-Uganda
Dr. Esther Katuura (MSc, PDGE, PhD), Department of Plant Sciences, Microbiology and Biotechnology, MAK, College of Natural Sciences, Kamala-Uganda
Dr. John Odda (MS. Clinical Lab., PhD), Department of Pharmacology and Therapeutics, MAKCHS, Kampala-Uganda
Prof. DR. Zacharie Tsongo Kibendelwa (MD, PhD), Department of Surgery, Faculty of Medicine, University of Kisangani, DRC
Defense Chair:
The Dean School of Biomedical Sciences, College of Health Sciences, Makerere University
Embracing the AI+BT Era: Insights from Dr. Yin Ye’s Lecture at Makerere University’s College of Health Sciences
On Wednesday, October 23, 2024, the College of Health Sciences at Makerere University had the honor of hosting Dr. Yin Ye, Chief Executive Officer and Executive Director of BGI Group, for a highly anticipated lecture titled “Embracing the AI+BT Era: What Should We Do Next?” The event took place at the Davies Lecture Theatre, MakCHS, and was moderated by Dr. David P. Kateete, Ph.D., Dean of the School of Biomedical Sciences.
Dr. Yin Ye, a renowned expert in genomics and biotechnology, shared his visionary perspective on the integration of Artificial Intelligence (AI) and Biotechnology (BT) in modern science and medicine. His talk delved into the transformative potential of AI and biotechnology when combined, paving the way for revolutionary advancements in genomic research, medical diagnostics, and therapeutics.
Highlights of the Event:
Visit to the Vice Chancellor: The day began with a visit by Dr. Yin Ye to the Vice Chancellor’s office, accompanied by Awel, Bob Wang, and David Kateete.
Key Remarks: Opening remarks were made by distinguished officials including Prof. Moses Joloba, Executive Director of MakBRC, Prof. Richard Idro, Deputy Principal CHS, and Prof. Damalie Nakanjako, Principal CHS.
Dr. Yin Ye’s Lecture: The highlight of the event was Dr. Yin’s engaging lecture, where he explored how the convergence of AI and BT is poised to revolutionize fields such as genomics, disease prevention, and personalized medicine. He emphasized the need for research institutions and health professionals to embrace these technologies to stay at the forefront of innovation.
Additional Activities:
Following the lecture, there were light refreshments in the Dean’s Garden, a tour of the Genomics Facility and the H3Africa Biobank at the Department of Immunology and Molecular Biology, and finally, a dinner with the College Leadership.
This event marked a significant moment in the centenary celebrations of Makerere University, reinforcing its commitment to advancing health sciences through cutting-edge research and collaboration with global leaders like BGI Group.
The Science, Technology and Innovation Secretariat at Office of the President and Scientists from Cuba visits the Biomarker Discovery lab at MakBRC
On 6th/Oct/2024 MakBRC hosted a team of scientists from STI-OP and Cuba at the Biomarker Discovery lab, located at Kasangati. The guests were welcomed by Dr. Ivan Mwebaza, the Head of Research and Innovations at MakBRC who emphasized the importance of this collaboration towards research, training, R&D, and skills transfer between Uganda and Cuba.
The guests, led by Dr. David Seruka and Ms Leah Nabirye from STI-OP. Scientists from Empresa de Servicios Ingenieros Especializados, Cuba (ESINES) were led by Dr. Figueroa Fernandez; Business and Development Director, Dr.Portuondo Vazquez; Deputy Director, and Dr. Sardina Fagundo; the Chief Architect & Project Manager.
The team also included Dr. Leyva Hernandez who is the Commercial & Business Director at Biocubafarma Group of Company. Dr. Palenzuela Diaz represented Immuneesayo Centre in Havana. The Ugandan embassy in Havana was represented by Dr. Komakech Paul who is an administrative assistant and also a Medical Intern at Medical University of Havana.
The purpose of this visit was to identify facilities and capital investments that can foster synergies and collaborative Research and Development (R&D) between MakBRC, STI-OP, and Cuban institutions. The Biomarker Discovery lab is one of such facilities since it is a place where basic and translational analysis of target biological markers can be performed, and prototypes validated before they progress to commercial production. Currently the lab is equipped with a high-performance liquid chromatograph-triple quadrupole mass spectrometer (LC/MS/MS) with mass range of m/z 2 to 2000.
HPLC Mass spectrometry in the Biomarker Discovery lab
The guests commended MakBRC for its commitment to developing capacity and championing innovations that reduce and mitigate disease burden in Uganda and beyond. They reiterated the importance of such high-tech research labs in preventing, detecting and responding to healthcare challenges and biologic threats.
The guests also visited the renovated and remodeled space where the HIV drug resistance and reservoir labs are to be established. Dr. Mwebaza informed the guests about the need for an HIV drug resistance testing facility as it ensures patients are given medications that are pharmacologically effective against the strain of HIV they have.
HPLC Mass spectrometry in the Biomarker Discovery lab
Such lab is crucial for mitigating the spread of antimicrobial resistance, and it is one step towards personalized HIV treatment in Uganda. He also informed the guests that by establishing facilities that conducts research on HIV reservoirs, MakBRC is positioning Ugandan Scientists to be part of the quest for the HIV cure.
Date: Wednesday, 23rd October 2024 Time: 4:00 PM (EAT) Venue: Davies Lecture Theatre, MakCHS Guest Speaker: Dr. Yin Ye, Chief Executive Officer and Executive Director, BGI Group
Join us for an enlightening seminar on the future of technology and biotechnology, titled “Embracing the AI+BT Era: What Should We Do Next?”, featuring Dr. Yin Ye. As a prominent leader in genomics and biotechnology, Dr. Yin Ye brings a wealth of knowledge and experience to discuss the integration of artificial intelligence with biotechnology and its implications for the future.
About the Speaker:
Dr. Yin Ye holds a Ph.D. in Bioengineering from the University of Copenhagen and has been with BGI Group since 2002. Under his leadership, BGI has become a global leader in providing genomics solutions to top institutions worldwide. His expertise extends to pharmaceutical companies, healthcare providers, and research organizations, where he offers reliable diagnostic and treatment evidence, and life sciences and medical innovations.
He is also a part-time professor at Dalian University of Technology and plays a pivotal role in managing human genetic resources in China. Dr. Yin Ye serves on various professional committees, including the Chinese Anti-Cancer Association and the Shenzhen Standardization Association.
Chair:
Dean, School of Biomedical Sciences, MakCHS
Join Us Live via Zoom: Zoom Link:https://rb.gy/1r27mv Meeting ID: 889 3235 3299 Passcode: 881192
MakBRC is a Ugandan registered Not-for-Profit Organization fully owned by Makerere University established within Makerere University College of Health Sciences.
